Colorectal cancer is the second most common cause of cancer related deaths in the US. Despite the progress in our understanding of the molecular characteristics of colorectal cancer, the go-to treatment remains surgical excision along with chemotherapy. However, this approach entails a number of adverse effects most of which can be traced back to non-specific targeting and toxicity. We seek to utilize our "intelligent" classifier to express proteins of therapeutic interest upon identifying a cell as cancerous AND NOT in healthy cells.